Ati Cardiovascular System Meds (Cardiac Rhythm)

Front 1

antidysrhythmic meds CLASS I

Back 1

sodium channel blockers stabilize cardiac membranes
Divided into 3 groups, IA, IB, IC

Front 2

antidysrhytmics Class IA

Back 2

procainamide (Pronestyl, Procanbid) oral, I

Front 3

quinidine gluconate (Quinaglute Dura-Tabs)

Back 3

antidysrthymics Class IA

Front 4

quinidine sulfate (Quinidex Extentabs)

Back 4

antidysrhythmics Class IA

Front 5

disopyramide (Norpace)

Back 5

antidysrhythmics Class IA

Front 6

antidysrhythmics Class IB

Back 6

prototype: lidocaine (Xylocaine) IV

Front 7

mexiletine (Mextil)

Back 7

antidysrhythmics Class IB

Front 8

Tocainide (Tonocard)

Back 8

antidysrhythmics Class IB

Front 9

antidysrythmics CLass IC

Back 9

Prototype: propadfenone (Rythmol) oral

Front 10

felcainide (Tambocor)

Back 10

antidysrhythmic Class IC

Front 11

Class II antidysrythmic

Back 11

beta-adrenergic blockers prevent sympathetic nervous system stimulation of the heart.

prototype: propranolol hydrochloride (Inderal)

Front 12

esmolol hydrochloride (Breviblock)

Back 12

Class II antidysrhythmic

Front 13

acebutolol hydrochloride (Sectral)

Back 13

Class II antidysrhythmic

Front 14

Class III antidysrhythmic meds

Back 14

potassium channel blockers prolong the action potential and refractory period of the cardiac cycle

prototype: amiodarone (Cordarone, Pacerone)- oral, IV

Front 15

Soltalol (Betapace)

Back 15

Class III antidysrhythmic

Front 16

Ibutilide (Corvert)

Back 16

CLass III antidysrhythmic

Front 17

Doefetilide (Tikosyn)

Back 17

Class III antidysrhythmic

Front 18

Class IV antidysrhythmic

Back 18

calcium channel blockers depress depolarization and decrease oxygen demand of the heart

Proto: verapamil (Calan)- oral, IV

Front 19

diltiazern (Cardizem)

Back 19

Class IV antidysrhythmic

Front 20

other antidysrhythmic meds

Back 20

adenosine (Adenocard) IV
digoxin (Lanoxin) oral, IV

Front 21

Class IA MOA

Back 21

decrease electrical conduction
decrease automaticity
decrease rate of repolarization

Front 22

Class IA use

Back 22

supraventricular tachycardia
ventricular tachcardia
atrial flutter
atrial fibrillation

Front 23

Class IB MOA

Back 23

decreased electrical conduction
decrease automaticity
increase rate of repolarization

Front 24

Class IB use

Back 24

short term use for ventricular dysrhythmias

Front 25

Class IC MOA

Back 25

decreace electrical conduction
decrease excitability
increase rate of polarization

Front 26

Class IC use

Back 26

SVT

Front 27

Class II MOA

Back 27

decrease heart rate
slow rate of conduction through SA node
decrease atrial ectopic stimulation

Front 28

Class II use

Back 28

A-fib, atrial flutter, paroxysmal SVT, hypertension, angina

Front 29

Class III MOA

Back 29

decrease rate of repolarization
decrease electrical conduction
decrease contractility
decrease automaticity

Front 30

Class III use

Back 30

coversion of a-fib- oral route
recurrent ventricular fibrillation
recurrent ventricular tachycardia

Front 31

Class IV calcium channel blockers
veramapil, diltiazem MOA

Back 31

decrease force of contraction
decrease heart rate
slow rate of conduction through the SA and AV nodes

Front 32

Class IV calcium channel blockers
veramapil, diltiazem USEs

Back 32

atrial fibrillation and flutter
SVT
hypertension
angina pectoris

Front 33

adenosine MOA

Back 33

decrease electrical conduction through AV node

Front 34

adenosine use

Back 34

paroxysmal SVT
Wolf-Parkinson white syndrome

Front 35

digoxin MOA

Back 35

decrease electrical conduction through AV node
Increase myocardial contraction

Front 36

digoxin use

Back 36

HF, a-fib, and flutter
paroxysmal SVT

Front 37

Procainamide adverse

Back 37

systemic lupus syndrome
neutropenia and thrombocytopenia
cardiotoxicity

Monitor procainamide level : 4-8 mcg/mL, BP, vitals, ECG, blood counts

Front 38

lidocaine adverse

Back 38

CNS effects, respiratory arrest

administer phenytoin to control seizure activity

Front 39

propafenone adverse

Back 39

bradycardia, heart failure, dizziness, weakness

Front 40

propranolol adverse

Back 40

hypotension, bradycardia, heart failure, fatigue

Front 41

amiodarone adverse

Back 41

pulmonary toxicity, sinus bradycardia and AV block, which may lead to heart failure
visual disturbances
liver and thyroid dysfunction, GI disturbances
CNS effects
phlebitis with IV admin
hypotension, bradycardia, AV block

Front 42

verpamil adverse

Back 42

bradycardia, hypotension, heart failure, constipation

Front 43

adenosine adverse

Back 43

sinus bradycardia, flushing of the face

Front 44

digoxin adverse

Back 44

bradycardia, hypotension, toxicity, nausea, vomiting, dysrhythmias- hold dose if heart rate less than 60/min

Front 45

antidysrhythmic adverse

Back 45

toxicity is a major concern for antidysrhythmics
can lead to increased cardiac dysrhythmias

Front 46

antidysrhythmics contraindications

Back 46

heart block, bradycardia, liver, kidney, respiratory problems

Front 47

antidysrhythmics interventions/client education

Back 47

Monitor ECG and blood pressure
monitor for toxicity
monitor digoxin level

Front 48

antidysrhythmics interactions

Back 48

concurrent use of atenolol, esmolol, or propanolol may cause additive effects of both meds
beta blockers may cause heart failure
methylxanthines
dipyridamole
corticosteroids
diuretics
thiazides
amphotericin B
(decreased potassium levels)
antacids and metoclopramide